Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) is associated with synapse loss. Souvenaid, containing the specific nutrient combination Fortasyn Connect, was designed to improve synapse formation and function. The NL-ENIGMA study explored the effect of Souvenaid on synapse function in early AD by asses...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (N Y)
Main Authors: Scheltens, Nienke M.E., Briels, Casper T., Yaqub, Maqsood, Barkhof, Frederik, Boellaard, Ronald, van der Flier, Wiesje M., Schwarte, Lothar A., Teunissen, Charlotte E., Attali, Amos, Broersen, Laus M., van Berckel, Bart N.M., Scheltens, Philip
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2019
Assuntos:
Featured Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804721/
https://ncbi.nlm.nih.gov/pubmed/31650005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.08.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares